Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes

Denise L. Faustman; Limei Wang; Yoshiaki Okubo; Douglas Burger; Liqin Ban; Guotong Man; Hui Zheng; David Schoenfeld; Richard Pompei; Joseph Avruch; David M. Nathan

doi:10.1371/journal.pone.0041756

Loading metrics

Open Access

Peer-reviewed

Research Article

Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes

Denise L. Faustman ,

* E-mail: faustman@helix.mgh.harvard.edu

Affiliation The Immunobiology Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Limei Wang,

Affiliation The Immunobiology Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Yoshiaki Okubo,

Affiliation The Immunobiology Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Douglas Burger,

Affiliation The Immunobiology Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Liqin Ban,

Affiliation The Immunobiology Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Guotong Man,

Affiliation The Immunobiology Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Hui Zheng,

Affiliation Department of Biostatistics, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯
David Schoenfeld,

Affiliation Department of Biostatistics, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯
Richard Pompei,

Affiliation Diabetes Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯
Joseph Avruch,

Affiliation Diabetes Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯
David M. Nathan

Affiliation Diabetes Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯

Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes

Denise L. Faustman,
Limei Wang,
Yoshiaki Okubo,
Douglas Burger,
Liqin Ban,
Guotong Man,
Hui Zheng,
David Schoenfeld,
Richard Pompei,
Joseph Avruch

Published: August 8, 2012
https://doi.org/10.1371/journal.pone.0041756

Reader Comments (2)

Post a new comment on this article

1 Response

17 Aug 2012
23:17 GMT
Most Recent

Media Coverage of This Article Posted by PLOS_ONE_Group on 10 Aug 2012 at 21:52 GMT

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Autoantibodies
Is the Subject Area "Autoantibodies" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
Regulatory T cells
Is the Subject Area "Regulatory T cells" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.
Cell staining
Is the Subject Area "Cell staining" applicable to this article?

Thanks for your feedback.
Epstein-Barr virus
Is the Subject Area "Epstein-Barr virus" applicable to this article?

Thanks for your feedback.